Burden of RSV in adults with asthma – literature review 2025
A literature review (ref 1) published in 2025 summarising evidence on the burden of RSV in adults with asthma or COPD highlighted that:
- A population-based study in New Zealand reported that the adjusted risk of RSV hospitalisation increased by 6.7; 7.6 and 8.2 folds in people with asthma aged 18-49; 50-64 and 65-80 respectively, compared to people without asthma.(ref 1, 2)
- Two studies reported that 49-65% of patients 60 years and older with asthma hospitalised with RSV experienced asthma exacerbations.(ref 1)
Categories:
RSV
Entry Date:
21/05/2025
Source 1 Name:
12. Penders Y, Brusselle G, Falsey AR, et al. Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review. Curr Allergy Asthma Rep. 2025 Feb 25;25(1):14. doi: 10.1007/s11882-025-01194-w.
Source 2 Name:
15. Prasad N, Walker TA, Waite Bet al. Respiratory Syncytial Virus-Associated Hospitalizations Among Adults With Chronic Medical Conditions. Clin Infect Dis. 2021 Jul 1;73(1):e158-e163. doi: 10.1093/cid/ciaa730.